Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.056 | 0.7 |
mRNA | salermide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.054 | 0.7 |
mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.7 |
mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | Imatinib | FIMM | pan-cancer | AAC | -0.056 | 0.7 |
mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |